News

Dr Ma will report directly to Shuhui Chen, chief scientific officer of WuXi PharmaTech. Dr Ma has received his PhD in organic chemistry from the University of Tokushima,

The registry is open to all phenylketonuria (PKU) clinics within the US, and all patients screened for Kuvan responsiveness are eligible for enrollment in the registry. Also, from

The Francis trial is designed to assess the impact of oral varespladib on known biological markers of cardiovascular risk. It will enroll up to 500 patients that will

Paul Lisenby, CEO of XTend Medical, said: “Once the FDA has cleared the device for sale, we will immediately begin marketing the product to our managed care companies

A total of 60 healthy young adults participated in the double-blind, dose-escalating Phase I study, which was designed to assess the safety and immunogenicity of the M2e universal

In this positive and negative controlled study, Proellex showed no microscopic evidence for tumor induction as compared to both controls. Proellex was tested at 10, 40 and 100

Gentiva will receive $84 million in cash and a $25 million interest-bearing seller note upon the closing of the transaction. In addition, Gentiva will retain 31% of the

The technology licensed by Embryome Sciences covers methods to produce induced pluripotent stem (iPS) cells that do not carry the viral vectors or added genes. Sublicensed from Advanced

The proteasome is an important cellular structure necessary for the growth and function of cancer cells and inhibition of the proteasome has been shown to promote cell cycle